How Maois Affect Rem Sleep And Dreaming

MAO inhibitors, or monoamine oxidase inhibitors, are a class of antidepressants that have been observed to suppress REM sleep. They work by blocking the monoamine oxidase enzyme, which breaks down neurotransmitters such as serotonin, norepinephrine, and dopamine. These neurotransmitters play a crucial role in regulating mood, sleep-wake cycles, and memory. While MAO inhibitors can be effective in treating depression, they are one of the least commonly prescribed antidepressants due to safety concerns, side effects, and dietary restrictions.

MAOIs suppress REM sleep

MAOIs (monoamine oxidase inhibitors) are a class of antidepressants that work by blocking the monoamine oxidase enzyme, which breaks down neurotransmitters such as serotonin, norepinephrine, and dopamine. These neurotransmitters play a crucial role in regulating mood, sleep-wake cycles, memory, appetite, and social behaviour. By blocking the breakdown of these neurotransmitters, MAOIs increase their levels in the brain, leading to an improvement in depression symptoms.

While MAOIs can be effective in treating depression, they are one of the least commonly prescribed antidepressants due to safety concerns and side effects. One of the most significant effects of MAOIs is the suppression of REM (rapid-eye-movement) sleep. This suppression can be drastic, and in some cases, REM sleep is completely eliminated for extended periods. For example, a study by Landolt et al. (2001) found that three depressed patients treated with the MAOI phenelzine experienced a complete elimination of REM sleep for three to six months.

The exact mechanism underlying MAOI-induced REM sleep suppression is not fully understood. However, it is speculated that the drug may be substituting for REM sleep, affecting REM sleep control mechanisms rather than its function, or that REM sleep may not have unique benefits that cannot be met by non-REM sleep or wakefulness.

Despite the suppression of REM sleep, MAOIs have been used safely and successfully to treat patients with depression or narcolepsy for prolonged periods. While complete REM sleep suppression can occur, it is important to note that short REM sleep episodes may reappear after a few months of medication. Additionally, the suppression of REM sleep does not seem to have obvious adverse effects on patients.

MAOIs are antidepressants

MAOIs (monoamine oxidase inhibitors) are a class of antidepressants that work by blocking the monoamine oxidase enzyme, which breaks down different types of neurotransmitters in the brain, including serotonin, norepinephrine, and dopamine. By blocking this enzyme, MAOIs increase the levels of these neurotransmitters, which play important roles in regulating mood, sleep-wake cycles, memory, appetite, social behaviour, and sexual desire.

MAOIs were the first type of antidepressant invented, but they are now one of the least commonly prescribed due to safety concerns around food and drug interactions. They are typically only prescribed if all other classes of antidepressants have failed to improve symptoms of depression. This is because non-selective MAOIs carry a high risk of side effects such as serotonin syndrome, hypertensive crisis, and dietary and drug interactions.

Selective MAOIs, particularly MAO-B inhibitors, have a safer side-effect profile, especially at low doses. A trial using the MAO-B inhibitor selegiline in a small group of patients with narcolepsy found dose-dependent nighttime REM sleep suppression with increased REM sleep latency, as well as improved daytime alertness, decreased sleep attacks, and diminished cataplexy symptoms. Another study found selegiline-related daytime alertness improvement comparable to amphetamines. These results suggest that selegiline can be considered as a second-line therapy for cataplexy and daytime sleepiness.

MAOIs can be taken orally in tablet or capsule form, or in the case of selegiline, via a skin patch. While they can be effective in treating depression, it's important to carefully consider the potential risks and side effects and always consult a healthcare professional before taking any medication.

MAOIs are used to treat Parkinson's disease

MAO-inhibitors (MAOIs) are among the earliest drugs used to treat Parkinson's disease (PD). They can be used with or without levodopa. Non-selective MAOIs, such as tranylcypromine, have limited use in treating depression in PD due to their side-effect profile. Instead, selective and reversible MAO-A inhibitors are recommended for their easier clinical handling. For treating akinesia and motor fluctuations, selective irreversible MAO-B inhibitors selegiline and rasagiline are recommended. They are safe and well-tolerated at the recommended daily doses.

MAOIs have three types: older, irreversible non-selective agents such as phenelzine and tranylcypromine; irreversible, selective MAO-B inhibitors; and reversible, selective MAO-A inhibitors. The clinical indications and efficacy of MAOIs are established for disorders such as PD, depressive disorders, and anxiety disorders.

MAO-B inhibitors may be used alone in the early stages of PD or in combination with other treatments, like carbidopa-levodopa therapy. They have been shown to have a modest effect on relieving the symptoms of PD. MAO-B inhibitors may reduce the motor fluctuations seen in many people with PD. People treated with carbidopa-levodopa often experience fluctuating symptoms of PD described as "on" and "off" episodes. "On" episodes are when the medicine is working and symptoms are minimal, while "off" episodes are when the medicine has not yet taken effect or is wearing off, causing worsened symptoms.

MAO-B inhibitors work by blocking the action of the MAO enzyme, which plays a role in the breakdown of neurotransmitters like dopamine. Levodopa therapy provides the precursor to dopamine, and adding an MAO-B inhibitor slows the breakdown of levodopa and dopamine in the brain, boosting the effect of levodopa.

Examples of MAO-B inhibitors used to treat PD include Eldepryl (selegiline hydrochloride) tablets, Zelapar (selegiline hydrochloride) orally disintegrating tablet, Azilect (rasagiline) tablet, and Xadago (safinamide) tablet. The most common side effects of selegiline include dyskinesia, while the most common side effects of rasagiline are increased dyskinesia and orthostatic hypotension.

MAOIs can cause serotonin syndrome

MAOIs, or monoamine oxidase inhibitors, are a class of antidepressants that have long been known to suppress REM sleep. They work by blocking the monoamine oxidase enzyme, which breaks down different types of neurotransmitters in the brain, including serotonin, dopamine, and norepinephrine. While MAOIs can be effective in treating depression, they also come with several risks and side effects, one of which is serotonin syndrome.

Serotonin syndrome, or serotonin toxicity, is a potentially life-threatening condition caused by excess serotonin in the synapses of the brain. It typically occurs when two drugs that increase serotonin are used together or when there is an overdose of a single serotonin-elevating drug. MAOIs are one of the most common culprits, as they slow down the breakdown of serotonin. When combined with other serotonin-enhancing drugs, such as selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs), the risk of serotonin syndrome increases significantly.

The symptoms of serotonin syndrome can range from mild to severe. Mild symptoms may include nervousness, insomnia, nausea, diarrhea, tremors, and dilated pupils. More severe symptoms can include hyperreflexia, clonus (rhythmic muscle spasms), tachycardia (increased heart rate), tachypnea (increased breathing rate), confusion, delirium, and rhabdomyolysis. In some cases, serotonin syndrome can be fatal if left untreated.

To prevent serotonin syndrome, it is crucial to exercise caution when prescribing MAOIs and other serotonergic drugs. Patients should be educated about the risks and encouraged to report any symptoms indicative of serotonin syndrome. Additionally, it is important to avoid combining MAOIs with other antidepressants, such as SSRIs, as this can increase the risk of serotonin syndrome.

While MAOIs can effectively treat depression and other nervous system disorders, it is important to carefully consider the benefits against the potential risks, including serotonin syndrome. These drugs should only be prescribed when other treatment options have been unsuccessful, and patients should be closely monitored to ensure their safety.

MAOIs have side effects

The risk of suicidal thoughts or behavior is especially prominent in children, teens, and young adults under the age of 25. It is crucial to monitor for any signs of suicidal ideation when taking MAOIs and to seek immediate medical help if needed.

Another rare but potentially life-threatening complication is serotonin syndrome, which can occur when MAOIs are taken in combination with other medications that increase serotonin levels, such as SSRIs or opioids. Serotonin syndrome is characterized by nausea, vomiting, muscle twitching, involuntary contractions, spasms, sweating, shivering, and side-to-side eye movements. Severe symptoms include confusion, delirium, rapid heart rate, high blood pressure, and loss of consciousness.

Antidepressant discontinuation syndrome can occur if MAOIs are suddenly stopped after being taken for at least six weeks. This syndrome includes flu-like symptoms, dizziness, sensory issues, anxiety, irritability, and agitation, typically lasting one to two weeks.

One of the most significant risks associated with MAOIs is the potential for dangerous food interactions. MAOIs prevent the breakdown of tyramine, a substance found naturally in the body and certain foods and drinks. If MAOIs are combined with a high tyramine diet, it can lead to a sudden and dangerous increase in blood pressure, known as the tyramine pressor response, which in rare cases can trigger a cerebral hemorrhage and result in death. Therefore, it is essential to follow dietary restrictions and avoid foods with high tyramine levels, such as aged cheese, liver, overripe fruits, fermented beers, and artisan sourdough bread.

MAOIs can also cause sleep disturbances, including insomnia and a reduction in REM sleep. This is likely due to the central stimulatory effect of increased monoamines in the brain.

Overall, while MAOIs can be effective in treating depression and other conditions, it is crucial to carefully consider and monitor for these potential side effects and complications.

Frequently asked questions